| Product Code: ETC9514786 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname continues to rely on imports for large molecule drug substances, with the top exporting countries in 2024 being the United States, Netherlands, Brazil, Peru, and the United Kingdom. The market shows high concentration with a high Herfindahl-Hirschman Index (HHI) in 2024. However, the compound annual growth rate (CAGR) from 2020 to 2024 is notably negative at -22.78%. Moreover, the growth rate from 2023 to 2024 experienced a significant decline of -60.7%, indicating a challenging landscape for large molecule drug substance imports in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Large Molecule Drug Substance CDMO Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Suriname Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Suriname Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologic drugs |
4.2.2 Rise in outsourcing of drug manufacturing activities by pharmaceutical companies |
4.2.3 Technological advancements in large molecule drug manufacturing processes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for large molecule drug manufacturing |
4.3.2 High initial investment costs for setting up large molecule drug manufacturing facilities |
5 Suriname Large Molecule Drug Substance CDMO Market Trends |
6 Suriname Large Molecule Drug Substance CDMO Market, By Types |
6.1 Suriname Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Suriname Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Suriname Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Suriname Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Suriname Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Suriname Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Average lead time for manufacturing large molecule drug substances |
8.2 Percentage of successful technology transfers |
8.3 Number of new strategic partnerships established with pharmaceutical companies |
9 Suriname Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Suriname Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Suriname Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Suriname Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Suriname Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Suriname Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Suriname Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |